National Cancer Centre, Singapore: Lung Neoplasms trials

The registry lists 10 Lung Neoplasms studies with National Cancer Centre, Singapore as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLCRecruitingNCT06418412
• SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)RecruitingNCT05724264Not applicable
• Phase 2 Study of Dacomitinib in NSCLCActive, not recruitingNCT04027647Phase 2
• Molecular Profiling ProjectSuspendedNCT04025515
• Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCTerminatedNCT03711422Phase 1
• Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung CancerTerminatedNCT03091491Phase 2
• PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker DiscoveryCompletedNCT02804776Phase 2
• Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung CancerCompletedNCT02801734Not applicable
• A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFRCompletedNCT01570296Phase 1
• Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerCompletedNCT00702182Phase 1